Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACT NASDAQ:CLOV NYSE:ESNT NYSE:OSCR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACTEnact$36.25-1.4%$37.59$30.79▼$39.47$5.35B0.57406,683 shs102,020 shsCLOVClover Health Investments$2.72+4.8%$2.79$2.12▼$4.87$1.39B2.17.31 million shs5.74 million shsESNTEssent Group$60.44-1.4%$61.95$51.61▼$65.90$5.96B0.88728,653 shs364,240 shsOSCROscar Health$21.90+1.1%$17.05$11.20▼$22.78$5.66B1.8914.14 million shs9.95 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACTEnact0.00%-5.93%-4.64%-1.55%+1.43%CLOVClover Health Investments0.00%-19.06%-5.82%-10.38%-35.89%ESNTEssent Group0.00%-5.42%-4.03%+2.35%-4.59%OSCROscar Health0.00%+17.71%+11.65%+29.07%+7.60%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACTEnact$36.25-1.4%$37.59$30.79▼$39.47$5.35B0.57406,683 shs102,020 shsCLOVClover Health Investments$2.72+4.8%$2.79$2.12▼$4.87$1.39B2.17.31 million shs5.74 million shsESNTEssent Group$60.44-1.4%$61.95$51.61▼$65.90$5.96B0.88728,653 shs364,240 shsOSCROscar Health$21.90+1.1%$17.05$11.20▼$22.78$5.66B1.8914.14 million shs9.95 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACTEnact0.00%-5.93%-4.64%-1.55%+1.43%CLOVClover Health Investments0.00%-19.06%-5.82%-10.38%-35.89%ESNTEssent Group0.00%-5.42%-4.03%+2.35%-4.59%OSCROscar Health0.00%+17.71%+11.65%+29.07%+7.60%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACTEnact 0.00N/AN/AN/ACLOVClover Health Investments 2.25Hold$4.3759.66% UpsideESNTEssent Group 2.44Hold$64.836.82% UpsideOSCROscar Health 1.40Strong Sell$12.07-44.87% DownsideCurrent Analyst Ratings BreakdownLatest CLOV, ESNT, ACT, and OSCR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/6/2025ESNTEssent GroupBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetCautious$59.00 ➝ $66.009/27/2025ACTEnactWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (A-)9/27/2025CLOVClover Health InvestmentsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025ESNTEssent GroupWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B)9/27/2025OSCROscar HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)8/14/2025OSCROscar HealthPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$14.00 ➝ $13.008/12/2025ESNTEssent GroupDOWLING & PARTNSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/8/2025ESNTEssent GroupKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeOutperform ➝ Market Perform8/8/2025ESNTEssent GroupCompass PointSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy8/8/2025ESNTEssent GroupRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform8/8/2025ESNTEssent GroupJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$60.00(Data available from 10/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACTEnact$1.22B4.40$4.64 per share7.86$32.53 per share1.12CLOVClover Health Investments$1.37B1.02N/AN/A$0.68 per share4.02ESNTEssent Group$1.24B4.81$7.04 per share8.62$52.76 per share1.15OSCROscar Health$9.18B0.62$0.13 per share172.42$4.06 per share5.39Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACTEnact$688.07M$4.398.307.942.1455.35%13.61%10.42%11/5/2025 (Estimated)CLOVClover Health Investments-$43.01M-$0.08N/AN/AN/A-2.68%-12.20%-6.95%11/5/2025 (Estimated)ESNTEssent Group$729.40M$6.858.878.432.6556.36%12.66%9.98%11/7/2025 (Estimated)OSCROscar Health$25.43M-$0.81N/A29.59N/A-1.50%-13.78%-2.99%11/6/2025 (Estimated)Latest CLOV, ESNT, ACT, and OSCR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/8/2025Q2 2025ESNTEssent Group$1.68$1.93+$0.25$1.93$317.46 million$319.14 million8/6/2025Q2 2025OSCROscar Health-$0.90-$0.89+$0.01-$0.89$2.88 billion$2.86 billion7/30/2025Q2 2025ACTEnact$1.11$1.15+$0.04$1.11$307.54 million$304.89 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACTEnact$0.842.30%N/A19.13%3 YearsCLOVClover Health InvestmentsN/AN/AN/AN/AN/AESNTEssent Group$1.242.04%N/A18.10%6 YearsOSCROscar HealthN/AN/AN/AN/AN/ALatest CLOV, ESNT, ACT, and OSCR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/8/2025ESNTEssent Groupquarterly$0.311.98%8/29/20258/29/20259/10/20257/30/2025ACTEnactquarterly$0.212.44%8/18/20258/18/20259/8/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACTEnact0.141.091.09CLOVClover Health InvestmentsN/A1.801.80ESNTEssent Group0.091.241.24OSCROscar Health0.260.860.86Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACTEnact18.03%CLOVClover Health Investments19.77%ESNTEssent Group93.00%OSCROscar Health75.70%Insider OwnershipCompanyInsider OwnershipACTEnact0.44%CLOVClover Health Investments24.07%ESNTEssent Group3.40%OSCROscar Health25.11%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACTEnact500147.51 million146.86 millionNot OptionableCLOVClover Health Investments680512.51 million389.15 millionOptionableESNTEssent Group35098.53 million95.18 millionOptionableOSCROscar Health2,400258.56 million193.63 millionOptionableCLOV, ESNT, ACT, and OSCR HeadlinesRecent News About These CompaniesOscar Health (OSCR) Is Up 13.2% After $410M AI-Focused Raise and New Employer Plan Partnership—Has The Bull Case Changed?1 hour ago | uk.finance.yahoo.comOscar Health, Inc. (NYSE:OSCR) Short Interest Down 30.3% in September2 hours ago | marketbeat.comOscar Health (OSCR) Nears 52-Week High on Pharma Tariff PauseOctober 4 at 11:51 AM | insidermonkey.comHennessy Advisors Inc. Decreases Position in Oscar Health, Inc. $OSCROctober 4 at 6:02 AM | marketbeat.com32,161 Shares in Oscar Health, Inc. $OSCR Bought by Fortis Capital Advisors LLCOctober 4 at 5:35 AM | marketbeat.comOscar Health (NYSE:OSCR) Stock Price Up 8.3% - Should You Buy?October 3 at 6:08 PM | marketbeat.comMatauro LLC Buys Shares of 70,314 Oscar Health, Inc. $OSCROctober 3 at 5:32 AM | marketbeat.comOscar Health, Inc. (OSCR) Outperforms Broader Market: What You Need to KnowOctober 2, 2025 | zacks.comOscar Health, Inc. (OSCR) Stock Falls Amid Market Uptick: What Investors Need to KnowSeptember 30, 2025 | zacks.comBosman Wealth Management LLC Takes $1.70 Million Position in Oscar Health, Inc. $OSCRSeptember 30, 2025 | marketbeat.comPerigon Wealth Management LLC Has $1.23 Million Position in Oscar Health, Inc. $OSCRSeptember 28, 2025 | marketbeat.com10 Hidden-Gem AI Stocks to Buy Right NowSeptember 27, 2025 | fool.comU.S. Capital Wealth Advisors LLC Makes New $482,000 Investment in Oscar Health, Inc. $OSCRSeptember 26, 2025 | marketbeat.comWhy Oscar Health (OSCR) Shares Are Falling TodaySeptember 26, 2025 | msn.comDefiance Launches OSCX: The First 2X Long ETF for Oscar Health, Inc.September 25, 2025 | globenewswire.comMario Schlosser Sells 395,000 Shares of Oscar Health (NYSE:OSCR) StockSeptember 25, 2025 | insidertrades.comInsider Selling: Oscar Health (NYSE:OSCR) Insider Sells 395,000 Shares of StockSeptember 24, 2025 | marketbeat.comAssenagon Asset Management S.A. Grows Stock Holdings in Oscar Health, Inc. $OSCRSeptember 23, 2025 | marketbeat.comOscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key FactsSeptember 22, 2025 | zacks.comModerately bullish activity in Oscar Health with shares down 2.77%September 22, 2025 | msn.comAnnex Advisory Services LLC Takes $802,000 Position in Oscar Health, Inc. $OSCRSeptember 22, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines3 Hot Tech Stocks With Bullish Charts and Ample UpsideBy Thomas Hughes | September 15, 2025Carmax: Now is the Time to Load Up On This Used Car StockBy Thomas Hughes | September 26, 2025Memes Are Back: Retail Investors Are Piling Into 3 Quantum StocksBy Dan Schmidt | September 29, 2025Rocket Lab’s Bullish Case Remains Intact Despite Recent OfferingBy Ryan Hasson | September 24, 2025AutoZone Pulls Into a Buy-the-Dip OpportunityBy Thomas Hughes | September 24, 2025CLOV, ESNT, ACT, and OSCR Company DescriptionsEnact NASDAQ:ACT$36.25 -0.53 (-1.44%) As of 01:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. It engages in writing and assuming residential mortgage guaranty insurance. The company also offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; contract underwriting services for mortgage lenders; and mortgage-related reinsurance products. It primarily serves originators of residential mortgage loans. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. operates as a subsidiary of Genworth Holdings Inc.Clover Health Investments NASDAQ:CLOV$2.72 +0.13 (+4.83%) As of 12:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.Essent Group NYSE:ESNT$60.44 -0.88 (-1.44%) As of 01:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Essent Group Ltd., through its subsidiaries, provides private mortgage insurance and reinsurance for mortgages secured by residential properties located in the United States. Its mortgage insurance products include primary, pool, and master policy. The company also provides information technology maintenance and development services; customer support-related services; underwriting consulting; and contract underwriting services, as well as risk management products and title insurance and settlement services. It serves the originators of residential mortgage loans, such as regulated depository institutions, mortgage banks, credit unions, and other lenders. Essent Group Ltd. was incorporated in 2008 and is based in Hamilton, Bermuda.Oscar Health NYSE:OSCR$21.90 +0.24 (+1.08%) As of 01:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Behind D-Wave's Massive Week (And Why Rivals Also Popped) Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback Alphabet: After Its Best Quarter in Decades, Is It Time to Buy? After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught? Starbucks Stock Slumps; This Competitor Shows Strength Broadcom’s VMware Push Takes Aim at Microsoft, Google, & Amazon How Berkshire's OxyChem Buy Cements Its Long-Term Strength The Trade Desk: 2 Signs of a Comeback, 1 Risk Ahead Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
